Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells |
Type de publication | Journal Article |
Year of Publication | 2017 |
Auteurs | Vargas TRivera, Cai Z, Shen Y, Dosset M, Benoit-Lizon I, Martin T, Roussey A, Flavell RA, Ghiringhelli F, Apetoh L |
Journal | NATURE COMMUNICATIONS |
Volume | 8 |
Pagination | 559 |
Date Published | SEP 15 |
Type of Article | Article |
ISSN | 2041-1723 |
Résumé | Autophagy, a catabolic mechanism that involves degradation of cellular components, is essential for cell homeostasis. Although autophagy favours the lineage stability of regulatory T cells, the contribution of autophagy to the differentiation of effector CD4 T cells remains unclear. Here we show that autophagy selectively represses T helper 9 (T(H)9) cell differentiation. CD4 T cells lacking Atg3 or Atg5 have increased interleukin-9 (IL-9) expression upon differentiation into T(H)9 cells relative to Atg3- or Atg5-expressing control cells. In addition, the T(H)9 cell transcription factor, PU.1, undergoes K63 ubiquitination and degradation through p62-dependent selective autophagy. Finally, the blockade of autophagy enhances T(H)9 cell anticancer functions in vivo, and mice with T cell-specific deletion of Atg5 have reduced tumour outgrowth in an IL-9-dependent manner. Overall, our findings reveal an unexpected function of autophagy in the modulation of T(H)9 cell differentiation and antitumour activity, and prompt potential autophagy-dependent modulations of T(H)9 activity for cancer immunotherapy. |
DOI | 10.1038/s41467-017-00468-w |